Challenges in Emerging Vaccines and Future Promising Candidates against SARS‐CoV‐2 Variants
T Ghildiyal, N Rai, J Mishra Rawat… - Journal of …, 2024 - Wiley Online Library
Since the COVID‐19 outbreak, the severe acute respiratory syndrome coronavirus 2 (SARS‐
COV‐2) virus has evolved into variants with varied infectivity. Vaccines developed against …
COV‐2) virus has evolved into variants with varied infectivity. Vaccines developed against …
[HTML][HTML] B cell somatic hypermutation following COVID-19 vaccination with Ad26. COV2. S
C Jacob-Dolan, M Lifton, OC Powers, J Miller… - Iscience, 2024 - cell.com
The viral vector-based COVID-19 vaccine Ad26. COV2. S has been recommended by the
WHO since 2021 and has been administered to over 200 million people. Prior studies have …
WHO since 2021 and has been administered to over 200 million people. Prior studies have …
[HTML][HTML] Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the …
PA Suhana, L Kusum, JV Shruti… - JMIR Research …, 2023 - researchprotocols.org
Background: COVID-19 is a recent major public health concern caused by the SARS-CoV-2
virus, with approximately 44.6 million COVID-19–positive cases and 530,000 deaths in India …
virus, with approximately 44.6 million COVID-19–positive cases and 530,000 deaths in India …
Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022
J Lei, P Soe - medRxiv, 2024 - medrxiv.org
Background Accurate estimates of the prevalence of infections play an important role in
COVID-19 surveillance. Older people are known to have higher risks of severe outcomes …
COVID-19 surveillance. Older people are known to have higher risks of severe outcomes …
Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort Study
ERA Vos, CCE van Hagen, D Wong, G Smits, M Kuijer… - medRxiv, 2023 - medrxiv.org
Background Repeated population-based SARS-CoV-2 serosurveillance is key in
complementing other surveillance tools. Aim Assessing trends in infection-and/or vaccine …
complementing other surveillance tools. Aim Assessing trends in infection-and/or vaccine …
A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines
M Bausch-Jurken, RS Dawson, F Ceddia… - Expert Review of …, 2024 - Taylor & Francis
Introduction Since the original COVID-19 vaccines were developed, abundant clinical trial
and real-world evidence evaluating the efficacy, effectiveness, and safety of COVID-19 …
and real-world evidence evaluating the efficacy, effectiveness, and safety of COVID-19 …
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors
A Gaviria, R Tamayo-Trujillo, E Paz-Cruz… - Frontiers in Cellular …, 2024 - frontiersin.org
Introduction Coronavirus Disease 2019 (COVID-19) is a severe respiratory illness caused by
the RNA virus SARS-CoV-2. Globally, there have been over 759.4 million cases and 6.74 …
the RNA virus SARS-CoV-2. Globally, there have been over 759.4 million cases and 6.74 …
[HTML][HTML] Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti-nucleocapsid IgG antibodies in Kragujevac, Serbia
N Cicaric, V Canovic, M Stojkovic, S Matic… - Acta …, 2023 - frontierspartnerships.org
Serological testing is a powerful tool for analyzing the infectious disease burden landscape.
Therefore, this study aimed to determine the seroprevalence against SARS-CoV-2 in the …
Therefore, this study aimed to determine the seroprevalence against SARS-CoV-2 in the …
SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020–July 2022
JG Petrie, D Pattinson, JP King… - American Journal of …, 2024 - academic.oup.com
Studies of SARS-CoV-2 incidence are important for response to continued transmission and
future pandemics. We followed a rural community cohort with broad age representation with …
future pandemics. We followed a rural community cohort with broad age representation with …
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African …
A Manirakiza, C Malaka… - PLOS Global Public …, 2023 - journals.plos.org
Healthcare workers (HCWs) are at high to very high risk for SARS-CoV-2 infection. The
persistence of this pandemic worldwide has instigated the need for an investigation of the …
persistence of this pandemic worldwide has instigated the need for an investigation of the …